title: Analysis of illegitimate genomic integration mediated by zinc-finger nucleases: implications for specificity of targeted gene correction.
abstract: BACKGROUND
  Formation of site specific genomic double strand breaks (DSBs), induced by the expression of a pair of engineered zinc-finger nucleases (ZFNs), dramatically increases the rates of homologous recombination (HR) between a specific genomic target and a donor plasmid. However, for the safe use of ZFN induced HR in practical applications, possible adverse effects of the technology such as cytotoxicity and genotoxicity need to be well understood. In this work, off-target activity of a pair of ZFNs has been examined by measuring the ratio between HR and illegitimate genomic integration in cells that are growing exponentially, and in cells that have been arrested in the G2/M phase.
  
  
  RESULTS
  A reporter cell line that contained consensus ZFN binding sites in an enhanced green fluorescent protein (EGFP) reporter gene was used to measure ratios between HR and non-homologous integration of a plasmid template. Both in human cells (HEK 293) containing the consensus ZFN binding sites and in cells lacking the ZFN binding sites, a 3.5 fold increase in the level of illegitimate integration was observed upon ZFN expression. Since the reporter gene containing the consensus ZFN target sites was found to be intact in cells where illegitimate integration had occurred, increased rates of illegitimate integration most likely resulted from the formation of off-target genomic DSBs. Additionally, in a fraction of the ZFN treated cells the co-occurrence of both specific HR and illegitimate integration was observed. As a mean to minimize unspecific effects, cell cycle manipulation of the target cells by induction of a transient G2/M cell cycle arrest was shown to stimulate the activity of HR while having little effect on the levels of illegitimate integration, thus resulting in a nearly eight fold increase in the ratio between the two processes.
  
  
  CONCLUSIONS
  The demonstration that ZFN expression, in addition to stimulating specific gene targeting by HR, leads to increased rates of illegitimate integration emphasizes the importance of careful characterization of ZFN treated cells. In order to reduce off-target events, reversible cell cycle arrest of the target cells in the G2/M phase is an efficient way for increasing the ratio between specific HR and illegitimate integration.
authors.affiliation: Section for Cellular and Genetic Therapy, Institute of Microbiology, Oslo University Hospital, Rikshospitalet, Gausdadalleen 21, 0349 Oslo, Norway. petter.angell.olsen@rr-research.no
authors.forename: Petter A
authors.initials: PA
authors.lastname: Olsen
authors.forename: Monika
authors.initials: M
authors.lastname: Gelazauskaite
authors.forename: Markus
authors.initials: M
authors.lastname: Randøl
authors.forename: Stefan
authors.initials: S
authors.lastname: Krauss
mesh_terms: D002453:Cell Cycle; D002460:Cell Line; D003851:Deoxyribonucleases / Q000737:chemistry / Q000378:metabolism*; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006801:Humans; D015202:Protein Engineering; D016335:Zinc Fingers
chemical_list: C485184:enhanced green fluorescent protein; D049452:Green Fluorescent Proteins; D003851:Deoxyribonucleases
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):11997-2002
references.pmid: 14514889
references.citation: DNA Repair (Amst). 2007 Jul 1;6(7):923-35
references.pmid: 17363343
references.citation: Genes Dev. 2004 Jun 1;18(11):1293-304
references.pmid: 15175261
references.citation: Nat Biotechnol. 2009 Sep;27(9):851-7
references.pmid: 19680244
references.citation: Nature. 1985 Sep 19-25;317(6034):230-4
references.pmid: 2995814
references.citation: Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1156-60
references.pmid: 8577732
references.citation: Mol Cell Biol. 2003 May;23(10):3558-65
references.pmid: 12724414
references.citation: Mol Cell Biol. 1994 Dec;14(12):8096-106
references.pmid: 7969147
references.citation: Mol Cell Biol. 2001 Jan;21(1):289-97
references.pmid: 11113203
references.citation: Curr Med Chem Anticancer Agents. 2005 Jul;5(4):363-72
references.pmid: 16101488
references.citation: Cell Res. 2008 Jan;18(1):134-47
references.pmid: 18157161
references.citation: Nature. 2005 Jun 2;435(7042):646-51
references.pmid: 15806097
references.citation: Curr Gene Ther. 2006 Aug;6(4):481-504
references.pmid: 16918336
references.citation: Biochem Biophys Res Commun. 2005 Sep 9;334(4):1191-1197
references.pmid: 16043120
references.citation: Nature. 2000 Jun 8;405(6787):697-700
references.pmid: 10864328
references.citation: Mol Cell Biol. 1997 Jan;17(1):267-77
references.pmid: 8972207
references.citation: Science. 2009 Jul 24;325(5939):433
references.pmid: 19628861
references.citation: Nat Biotechnol. 2007 Jul;25(7):778-85
references.pmid: 17603475
references.citation: Oncogene. 2008 Mar 13;27(12):1726-36
references.pmid: 17891177
references.citation: Nature. 2009 May 21;459(7245):442-5
references.pmid: 19404258
references.citation: Cell Stem Cell. 2009 Jul 2;5(1):97-110
references.pmid: 19540188
references.citation: Cell. 1987 Nov 6;51(3):503-12
references.pmid: 2822260
references.citation: Nat Biotechnol. 2008 Jul;26(7):808-16
references.pmid: 18587387
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16370-5
references.pmid: 17060623
references.citation: Nat Biotechnol. 2008 Jun;26(6):702-8
references.pmid: 18500334
references.citation: Environ Mol Mutagen. 2003;42(4):288-98
references.pmid: 14673874
references.citation: Mol Ther. 2008 Jul;16(7):1200-1207
references.pmid: 28178480
references.citation: Nat Biotechnol. 2007 Nov;25(11):1298-306
references.pmid: 17965707
references.citation: DNA Repair (Amst). 2009 Mar 1;8(3):298-308
references.pmid: 19071233
references.citation: DNA Repair (Amst). 2003 Oct 7;2(10):1147-56
references.pmid: 13679152
references.citation: Science. 2003 May 2;300(5620):764
references.pmid: 12730594
references.citation: Nucleic Acids Res. 2001 Oct 1;29(19):3975-81
references.pmid: 11574679
references.citation: Genetics. 2002 Jul;161(3):1169-75
references.pmid: 12136019
references.citation: Proc Natl Acad Sci U S A. 1988 Aug;85(16):6022-6
references.pmid: 2842757
references.citation: Nature. 2000 Nov 23;408(6811):433-9
references.pmid: 11100718
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10570-5
references.pmid: 9724744
references.citation: Nat Biotechnol. 2007 Jul;25(7):786-93
references.pmid: 17603476
references.citation: Genetics. 2006 Apr;172(4):2391-403
references.pmid: 16452139
references.citation: Mol Cell. 2007 Dec 14;28(5):739-45
references.pmid: 18082599
references.citation: Mol Cell. 2008 Jul 25;31(2):294-301
references.pmid: 18657511
references.citation: J Mol Med (Berl). 2008 Nov;86(11):1205-19
references.pmid: 18607557
references.citation: Genome Res. 2009 Jul;19(7):1279-88
references.pmid: 19470664
references.citation: Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1437-41
references.pmid: 11171969
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13296-301
references.pmid: 12271125
references.citation: Mol Ther. 2006 Feb;13(2):438-46
references.pmid: 16169774
references.citation: Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5172-7
references.pmid: 9560248
references.citation: Trends Biotechnol. 2005 Aug;23(8):407-19
references.pmid: 15993503
references.citation: Nature. 2009 May 21;459(7245):437-41
references.pmid: 19404259
references.citation: Gene Ther. 2008 Nov;15(22):1463-8
references.pmid: 18784746
references.citation: Nucleic Acids Res. 1990 Jun 25;18(12):3587-96
references.pmid: 2194165
references.citation: DNA Repair (Amst). 2005 Aug 15;4(9):1038-46
references.pmid: 15935739
references.citation: Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8403-10
references.pmid: 11459982
references.citation: Nat Methods. 2008 May;5(5):374-5
references.pmid: 18446154
references.citation: Exp Cell Res. 1980 Apr;126(2):397-405
references.pmid: 6153987
references.citation: Mol Cell Biol. 2000 Dec;20(23):9068-75
references.pmid: 11074004
references.citation: Trends Genet. 1996 Jun;12(6):224-8
references.pmid: 8928227
references.citation: Nat Methods. 2010 Feb;7(2):91; author reply 91-2
references.pmid: 20111032
references.citation: Nat Biotechnol. 2008 Jun;26(6):695-701
references.pmid: 18500337
references.citation: Science. 2003 May 2;300(5620):763
references.pmid: 12730593
references.citation: Mol Ther. 2005 Oct;12(4):610-7
references.pmid: 16039907
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3055-60
references.pmid: 17360608
references.citation: Mol Ther. 2008 Apr;16(4):707-17
references.pmid: 18334988
references.citation: J Cell Sci. 2004 Oct 1;117(Pt 21):4935-45
references.pmid: 15367581
references.citation: Mol Ther. 2008 Feb;16(2):352-358
references.pmid: 28178540
references.citation: Mol Ther. 2010 Apr;18(4):743-53
references.pmid: 20068556